Category Research

David A. Bond, MD

Researcher Spotlight: David A. Bond, MD The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital  Diffuse large B-cell lymphoma (DLBCL) is the mostcommon type of non-Hodgkin lymphoma (NHL). SinceDLBCL can advance quickly, it usually requires immediatetreatment, which…

Nicole Prutsch, PhD

Researcher Spotlight: Nicole Prutsch, PhD Dana-Farber Cancer Institute T-cell lymphomas represent a heterogeneous group of peripheral and cutaneous non-Hodgkin lymphomas (NHL) with a range of unmet clinical needs. Anaplastic large cell lymphoma (ALCL) is a CD30+ subtype of non-Hodgkin T-cell…

Elisa Mandato, PhD

Researcher Spotlight: Elisa Mandato, PhD Dana-Farber Cancer Institute Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) and the most common hematologic malignancy in the United States. Dr. Mandato’s LRF research project will involve developing…

Richa Kapoor, PhD

Researcher Spotlight: Richa Kapoor, PhD Perelman School of Medicine, University of Pennsylvania T-cell lymphomas are aggressive cancer types that exhibit clinical and genetic heterogeneity, and current therapies do not incorporate personalized medicine opportunities. Research has shown that cutaneous T-cell lymphoma…

Hannah Isles, PhD

Researcher Spotlight: Hannah Isles, PhD Weill Cornell Medicine Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin lymphoma (NHL). The recentidentification of DLBCL patient subgroups featuring distinct DNA mutation profiles have provided researchers with new opportunities to treat…

Alexandre Vinaud Hirayama, MD

Researcher Spotlight: Alexandre Vinaud Hirayama, MD Fred Hutchinson Cancer Research Center Chimeric antigen receptor (CAR) T cell therapy is a typeof immunotherapy that genetically modifies a patient’simmune cells to recognize and kill tumor cells. “CAR T cell therapy has shown…

Rui Guo, PhD

Researcher Spotlight: Rui Guo, PhD Brigham and Women’s Hospital, Harvard Medical School Epstein-Barr virus (EBV) was the first virus found to causeBurkitt lymphoma, a rare and aggressive form of non-Hodgkin lymphoma (NHL). The virus shuts down nearlyall its genes in…

Edmond Feris, PhD

Researcher Spotlight: Edmond Feris, PhD  Dartmouth-Hitchcock Norris Cotton Cancer Center Some of the most critical oncogenes responsible fortumor formation in humans are transcription factors. Dr.Feris’ LRF research project focuses on the study of howtranscriptional dysregulation can lead to carcinogenesis(the process…

Lydie Debaize, PhD

Researcher Spotlight: Lydie Debaize, PhD Dana-Farber Cancer Institute Most patients treated for mantle cell lymphoma (MCL)achieve complete remission. Nevertheless, a significantnumber of patients will eventually relapse due to theregrowing of rare cancer cells remaining in the bodyafter treatment, which is known…